1 / 8

Molecular Diagnostics Market Trends, Segmentation, Regional Outlook, Future Plan

Molecular Diagnostics Market size was valued at USD 25.17 Billion in 2023 and the total Molecular Diagnostics revenue is expected to grow at a CAGR of 7.14 % from 2024 to 2030, reaching nearly USD 40.79 Billion by 2030.

Koml20
Download Presentation

Molecular Diagnostics Market Trends, Segmentation, Regional Outlook, Future Plan

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MOLECULAR DIAGNOSTICS MARKET GLOBAL ANALYSIS REPORT 2024-2030 Published by: Rahul, Marketing Head

  2. Market Size & Overview: The global Molecular Diagnostics Market was valued at approximately USD 25.17 billion in 2023 and is projected to reach nearly USD 40.79 billion by 2030, growing at a CAGR of 7.14% from 2024 to 2030. Molecular diagnostics involves using genetic and proteomic information to detect, diagnose, and monitor diseases, integrating molecular biology techniques into medical diagnostics. Key players in this market include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, and Siemens Healthineers.

  3. Market Growth & Opportunities The market's expansion is driven by the rising incidence of infectious diseases and cancers, increased understanding and acceptance of personalized treatments, and continual advancements in biomarker discovery. The demand for point-of-care diagnostics has surged, especially highlighted during global health crises like the COVID-19 pandemic, necessitating rapid and accessible diagnostic solutions. Emerging economies present significant growth opportunities due to increased adoption of molecular diagnostics, supported by government initiatives and improving healthcare infrastructures. Sample Request Sample Request

  4. Market Segmentation by Product & Service Reagents & Kits Instruments Services & Software by Technology Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) DNA Sequencing & Next- generation Sequencing (NGS) In Situ Hybridization (ISH) DNA Microarrays Other Technologies by Test Type Lab Tests PoC Tests by Application Infectious Diseases Diagnostics Oncology Testing Genetic Testing Other Test Types by End User Diagnostic Laboratories Hospitals & Clinics Other

  5. Regional Analysis: • North America: This region holds a commanding position in the molecular diagnostics market, attributed to significant outbreaks of bacterial and viral diseases, a burgeoning need for point-of-care diagnostics, rapid technological advancements, and the presence of key market players. • Europe: The molecular diagnostics market in Europe is anticipated to witness significant growth, driven by the increasing prevalence of genetic and cardiovascular disorders and growing investments in proteomics and genomics research initiatives. According to WHO data from 2024, cardiovascular diseases are the leading cause of disability and premature death in the European Region, responsible for over 42.5% of all deaths annually. • Asia-Pacific (APAC): APAC is rapidly emerging as a significant market, with the region expected to grow at a forecasted CAGR of 11% from 2024 to 2029. This growth is driven by an expanding population base, improving healthcare infrastructure, and increasing awareness of advanced diagnostic techniques.

  6. Regional Analysis Regional Analysis 2025-2030 South America Middle East and Africa North America Asia Pacific Europe Customized Report Request Customized Report Request

  7. Merges and Acquisition ◦ The molecular diagnostics sector has witnessed significant consolidation through mergers and acquisitions: • Roche's Acquisition of GenMark Diagnostics: In March 2021, Roche announced it would acquire GenMark Diagnostics for $1.8 billion, aiming to enhance its molecular diagnostics portfolio. • Thermo Fisher's Acquisition of The Binding Site Group: In October 2022, Thermo Fisher acquired The Binding Site Group for $2.6 billion, strengthening its specialty diagnostics segment, particularly in oncology testing for multiple myeloma. • Hologic's Acquisition of Biotheranostics Inc.: Hologic, Inc. acquired Biotheranostics Inc., aiming to broaden its molecular diagnostics portfolio, particularly in oncology. Buy This Report Buy This Report

  8. Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com

More Related